Shares of Corteva, Inc. (NYSE:CTVA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-two ratings firms that are covering the firm, Marketbeat reports. Eight research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $82.80.
Several analysts recently issued reports on the company. Royal Bank Of Canada increased their target price on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Bank of America upped their price target on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Wells Fargo & Company increased their price objective on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. CICC Research boosted their target price on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Wednesday, February 11th. Finally, Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th.
Read Our Latest Report on Corteva
Insider Activity
Hedge Funds Weigh In On Corteva
Institutional investors have recently added to or reduced their stakes in the company. Total Investment Management Inc. bought a new position in shares of Corteva during the 2nd quarter valued at approximately $27,000. Activest Wealth Management increased its position in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the last quarter. JPL Wealth Management LLC bought a new stake in Corteva in the third quarter worth $25,000. True Wealth Design LLC raised its stake in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Corteva during the second quarter valued at $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Corteva Trading Up 0.5%
Shares of Corteva stock opened at $76.95 on Tuesday. The company has a market capitalization of $51.75 billion, a P/E ratio of 48.70, a P/E/G ratio of 2.63 and a beta of 0.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a fifty day moving average of $73.00 and a 200 day moving average of $69.03. Corteva has a fifty-two week low of $53.40 and a fifty-two week high of $80.90.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same period last year, the firm earned $0.32 earnings per share. The business’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts anticipate that Corteva will post 2.96 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio is 45.57%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump Planning to Use Public Law 63-43: Prepare Now
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
